Chiasma
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
831 Beacon St, Newton Center, Massachuse...Phone Number
(914) 234-2268Website
www.chiasma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Chiasma
Chiasma is a biopharma company focused on creating new drug products by marrying its proprietary technology to approved drugs. This enables drugs to be switched from injectable to oral, but importantly can also result in new indications or improved labels by reducing side effects."Explore more
Chiasma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chiasma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Chiasma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Chiasma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Chiasma
Check out if Chiasma is spiking on competitors!
Funding: Get notified immidiatlly once Chiasma has new funding data
Check if Chiasma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Chiasma had a recent Job posting/layoffs
Product Launch: Get notified when Chiasma launches new products
Recommended Actions
Find VP level buyers at Chiasma
Find 3 more new buyers
Compare Similar Companies to Chiasma
Compare insights from companies similar to Chiasma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Chiasma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Chiasma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Chiasma.
Chiasma financials insights
Gather financial insights about Chiasma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Debt
$9M
2015
Stock Offering
$101.8M
2020
Other Financing Round
$75M
Chiasma Tech Stack
A closer look at the technologies used by Chiasma
See more technologies
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
Left Company
Left Company
Executive Move
Left Company
Left Company
Executive Move
Left Company
Executive Move
Chiasma News & Media
Amryt Issues Ordinary Shares and Total Voting Rights
Amryt Issues Ordinary Shares and Total Voting RightsPublication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings
Publication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General MeetingsSHAREHOLDER ALERT: WeissLaw LLP Reminds CHMA, PFOH, PTON, and HGV Shareholders About Its Ongoing Investigations
NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212) 682-3025(888) 593-4771stockinfo@weisslawllp.com Chiasma, Inc. (NASDAQ: CHMA) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board ofChiasma Presents Positive Patient-Reported Outcomes Data from its MPOWERED™ Phase 3 Trial Comparing MYCAPSSA® to Long-Acting Injectables for the Maintenance Treatment of Adults with Acromegaly
--Data presented at AACE 2021 demonstrate patient quality of life and work productivity significantly improved in patients transitioning from injectable SSAs to MYCAPSSA®-- --Data presented at AACE 2021 demonstrate patient quality of life and work productivity significantly improved in patients transitioning from injectable SSAs to MYCAPSSA®--
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chiasma
Sign Up For FreeTo access detailed company insights
Chiasma is a biopharma company focused on creating new drug products by marrying its proprietary technology to approved drugs. This enables drugs to be switched from injectable to oral, but importantly can also result in new indications or improved labels by reducing side effects."... Read More
